A preliminary study of the relationship between promoter methylation of the ABCG1, GALNT2 and HMGCR genes and coronary heart disease

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Peng, Ping ^a   Wang, Lu ^b   Yang, Xi ^a   Huang, Xiaoyan ^a   Ba, Yanna ^a   Chen, Xiaoliang ^a   Guo, Jian ^a   Lian, Jiangfang ^a   Zhou, Jianqing ^a  

^a NINGBO UNIVERSITY   (China)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER G1; LIPID; ABC TRANSPORTER; ABCG1 PROTEIN, HUMAN; BIOLOGICAL MARKER; HMGCR PROTEIN, HUMAN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; N ACETYLGALACTOSAMINYLTRANSFERASE; POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE;

ABCG1 GENE; ADULT; AGE; AGED; ANGIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CHINESE; CONTROLLED STUDY; DIABETES MELLITUS; DNA METHYLATION; FEMALE; GALNT2 GENE; GENDER; GENE; GENETIC ASSOCIATION; HMGCR GENE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PROMOTER REGION; SMOKING; BLOOD; CORONARY ARTERY DISEASE; GENETICS; METABOLISM; MIDDLE AGED; RISK;

AGED; ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL MARKERS; CORONARY DISEASE; DNA METHYLATION; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL COA REDUCTASES; MALE; MIDDLE AGED; N-ACETYLGALACTOSAMINYLTRANSFERASES; PROMOTER REGIONS, GENETIC; RISK;

EID: 84905457857     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0102265     Document Type: Article

References (34)

1. (2004) WHO publishes definitive atlas on global heart disease and stroke epidemic. Indian J Med Sci 58: 405-406.
2. Viles-Gonzalez JF, Anand SX, Valdiviezo C, Zafar MU, Hutter R, et al. (2004) Update in atherothrombotic disease. Mt Sinai J Med 71: 197-208. (Pubitemid 38702103)
3. Yin YW, Sun QQ, Zhang BB, Hu AM, Liu HL, et al. (2013) Association between apolipoprotein E gene polymorphism and the risk of coronary artery disease in Chinese population: evidence from a meta-analysis of 40 studies. PLoS One 8: e66924.
4. Sadeghi M, Ghashghaei FE, Rabiei K, Roohafza H, Afshar H (2012) Is there any difference between non-obese male and female in response to cardiac rehabilitation programs? J Res Med Sci 17: 787-791.
5. Kahn HS (2005) The "lipid accumulation product" performs better than the body mass index for recognizing cardiovascular risk: a population-based comparison. BMC CardiovascDisord 5: 26.
6. Feinberg AP, Tycko B (2004) The history of cancer epigenetics. Nat Rev Cancer 4: 143-153. (Pubitemid 38198742)
7. Zhu S, Goldschmidt-Clermont PJ, Dong C (2005) Inactivation of monocarboxylate transporter MCT3 by DNA methylation in atherosclerosis. Circulation 112: 1353-1361. (Pubitemid 41266732)
8. Jaenisch R, Bird A (2003) Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet 33 Suppl: 245-254. (Pubitemid 36278835)
9. Post WS, Goldschmidt-Clermont PJ, Wilhide CC, Heldman AW, Sussman MS, et al. (1999) Methylation of the estrogen receptor gene is associated with aging and atherosclerosis in the cardiovascular system. Cardiovasc Res 43: 985-991. (Pubitemid 29413198)
10. Zhuang J, Peng W, Li H, Wang W, Wei Y, et al. (2012) Methylation of p15INK4b and expression of ANRIL on chromosome 9p21 are associated with coronary artery disease. PLoS One 7: e47193.
11. Jiang D, Zheng D, Wang L, Huang Y, Liu H, et al. (2013) Elevated PLA2G7 gene promoter methylation as a gender-specific marker of aging increases the risk of coronary heart disease in females. PLoS One 8: e59752.
12. Guay SP, Brisson D, Munger J, Lamarche B, Gaudet D, et al. (2012) ABCA1 gene promoter DNA methylation is associated with HDL particle profile and coronary artery disease in familial hypercholesterolemia. Epigenetics 7: 464-472.
13. Friso S, Lotto V, Choi SW, Girelli D, Pinotti M, et al. (2012) Promoter methylation in coagulation F7 gene influences plasma FVII concentrations and relates to coronary artery disease. J Med Genet 49: 192-199.
14. Jeemon P, Pettigrew K, Sainsbury C, Prabhakaran D, Padmanabhan S (2011) Implications of discoveries from genome-wide association studies in current cardiovascular practice. World J Cardiol 3: 230-247.
15. Oram JF, Vaughan AM (2006) ATP-Binding cassette cholesterol transporters and cardiovascular disease. Circ Res 99: 1031-1043. (Pubitemid 44729927)
16. Tietjen I, Hovingh GK, Singaraja RR, Radomski C, Barhdadi A, et al. (2012) Segregation of LIPG, CETP, and GALNT2 mutations in Caucasian families with extremely high HDL cholesterol. PLoS One 7: e37437.
17. Peng P, Lian J, Huang RS, Xu L, Huang Y, et al. (2012) Meta-analyses of KIF6 Trp719Arg in coronary heart disease and statin therapeutic effect. PLoS One 7: e50126.
18. Lopes-Virella MF, Stone P, Ellis S, Colwell JA (1977) Cholesterol determination in high-density lipoproteins separated by three different methods. ClinChem 23: 882-884. (Pubitemid 8088312)
19. Chen C (2001) A survey of the dietary nutritional composition of centenarians. Chin Med J (Engl) 114: 1095-1097.
20. Schumann G, Bonora R, Ceriotti F, Ferard G, Ferrero CA, et al. (2002) IFCC primary reference procedures for the measurement of catalytic activity concentrations of enzymes at 37 degrees C. International Federation of Clinical Chemistry and Laboratory Medicine. Part 4. Reference procedure for the measurement of catalytic concentration of alanine aminotransferase. ClinChem Lab Med 40: 718-724.
21. Schumann G, Canalias F, Joergensen PJ, Kang D, Lessinger JM, et al. (2010) IFCC reference procedures for measurement of the catalytic concentrations of enzymes: corrigendum, notes and useful advice. International Federation of Clinical Chemistry and Laboratory Medicine (IFCC)-IFCC Scientific Division. ClinChem Lab Med 48: 615-621.
22. Schumann G, Bonora R, Ceriotti F, Ferard G, Ferrero CA, et al. (2002) IFCC primary reference procedures for the measurement of catalytic activity concentrations of enzymes at 37 degrees C. International Federation of Clinical Chemistry and Laboratory Medicine. Part 6. Reference procedure for the measurement of catalytic concentration of gamma-glutamyltransferase. ClinChem Lab Med 40: 734-738.
23. Doumas BT, Peters T Jr (1997) Serum and urine albumin: a progress report on their measurement and clinical significance.Clin Chim Acta 258: 3-20. (Pubitemid 27064025)
24. Eastwood JA, Doering LV, Dracup K, Evangelista L, Hays RD (2011) Health-related quality of life: The impact of diagnostic angiography. Heart Lung 40: 147-155.
25. Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, et al. (2011) Heart disease and stroke statistics-2011 update: a report from the American Heart Association. Circulation 123: e18-e209.
26. Wang N, Ranalletta M, Matsuura F, Peng F, Tall AR (2006) LXR-induced redistribution of ABCG1 to plasma membrane in macrophages enhances cholesterol mass efflux to HDL. ArteriosclerThrombVascBiol 26: 1310-1316. (Pubitemid 44305375)
27. Wandall HH, Hassan H, Mirgorodskaya E, Kristensen AK, Roepstorff P, et al. (1997) Substrate specificities of three members of the human UDP-N-acetyl-alpha-D-galactosamine:Polypeptide N-acetylgalactosaminyltransferase family, GalNAc-T1, -T2, and -T3. J BiolChem 272: 23503-23514. (Pubitemid 27410917)
28. Holleboom AG, Karlsson H, Lin RS, Beres TM, Sierts JA, et al. (2011) Heterozygosity for a loss-of-function mutation in GALNT2 improves plasma triglyceride clearance in man. Cell Metab 14: 811-818.
29. Teslovich TM, Musunuru K, Smith AV, Edmondson AC, Stylianou IM, et al. (2010) Biological, clinical and population relevance of 95 loci for blood lipids. Nature 466: 707-713.
30. Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, et al. (2005) Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 366: 1267-1278.
31. Sharma P, Kumar J, Garg G, Kumar A, Patowary A, et al. (2008) Detection of altered global DNA methylation in coronary artery disease patients. DNA Cell Biol 27: 357-365. (Pubitemid 351969854)
32. Baylin SB (2005) DNA methylation and gene silencing in cancer. Nat ClinPractOncol 2 Suppl 1: S4-11.
33. Hesson LB, Cooper WN, Latif F (2007) The role of RASSF1A methylation in cancer. Dis Markers 23: 73-87. (Pubitemid 46333640)
34. Hiltunen MO, Turunen MP, Hakkinen TP, Rutanen J, Hedman M, et al. (2002) DNA hypomethylation and methyltransferase expression in atherosclerotic lesions. Vasc Med 7: 5-11. (Pubitemid 34654067)